Immunetrics offers novel hypothesis testing in a virtual patient to guide future experiments.

 

Our models can quickly answer questions that would be logistically difficult to determine outside of an in silico setting:

  • Predict outcomes from combination therapies
  • Predict long-term effects beyond protocol duration
  • Predict efficacy for alternative treatment strategies (dose, duration, schedule, route)
  • Optimize timing for critical care interventions
  • Incorporate pharmacokinetic/pharmacodynamic properties